Vibha Rani

Dr. Vibha Rani


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Life Sciences
Verified
Journal Article
Closed access
VRVibha Rani
Vibha Rani
GDGagan Deep
Gagan Deep
RSRakesh K. Singh
Rakesh K. Singh
KPKomaraiah Palle
Komaraiah Palle
UYUmesh C.S. Yadav
Umesh C.S. Yadav

1 February 2016 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
SMShivangi Mishra
Shivangi Mishra
TYTanuja Yadav
Tanuja Yadav
VRVibha Rani
Vibha Rani

15 May 2014 in Journal of Microscopy
Verified
Journal Article
Closed access
PDF file
NAN. Atale
N. Atale
SGS. Gupta
S. Gupta
UYU.C.S. Yadav
U.C.S. Yadav
VRVibha Rani
Vibha Rani

20 January 2013 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
SAS. Arora
S. Arora
RRR. Rana
R. Rana
ACA. Chhabra
A. Chhabra
AJA. Jaiswal
A. Jaiswal
VRVibha Rani
Vibha Rani

8 March 2012 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
BDBipasha Dey
Bipasha Dey
STSameer Thukral
Sameer Thukral
SKShruti Krishnan
Shruti Krishnan
MCMainak Chakrobarty
Mainak Chakrobarty
SGSahil Gupta
Sahil Gupta
VRVibha Rani
Vibha Rani

20 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
AGAnubhuti Gupta
Anubhuti Gupta
KSKunal Singh
Kunal Singh
SFSameen Fatima
Sameen Fatima
SASaira Ambreen
Saira Ambreen
SZsilke zimmermann
silke zimmermann
BIBerend Isermann
Berend Isermann
Diabetes mellitus is a metabolic disease largely due to lifestyle and nutritional imbalance, resulting in insulin resistance, hyperglycemia and vascular complications. Diabetic kidney disease (DKD) is a major cause of end-stage renal failure contributing to morbidity and mortality worldwide. Therapeutic options to prevent or reverse DKD progression are limited. Endothelial and glomerular filtration barrier (GFB) dysfunction and sterile inflammation are associated with DKD. Neutrophil extracellular traps (NETs), originally identified as an innate immune mechanism to combat infection, have been implicated in sterile inflammatory responses in non-communicable diseases. However, the contribution of NETs in DKD remains unknown. Here, we show that biomarkers of NETs are increased in diabetic mice and diabetic patients and that these changes correlate with DKD severity. Mechanistically, NETs promote NLRP3 inflammasome activation and glomerular endothelial dysfunction under high glucose stress in vitro and in vivo. Inhibition of NETs (PAD4 inhibitor) ameliorate endothelial dysfunction and renal injury in DKD. Taken together, NET-induced sterile inflammation promotes diabetes-associated endothelial dysfunction, identifying a new pathomechanism contributing to DKD. Inhibition of NETs may be a promising therapeutic strategy in DKD.